Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiaojing Huang has a total of 198 co-authors. Here are the top co-authors by number of shared publications:

  • Shuai Chen

    Clinical Research Center for Oral Tissue Deficiency Diseases of Fujian Province & Fujian Key Laboratory of Oral Diseases, Fujian Provincial Engineering Research Center of Oral Biomaterial, School and Hospital of Stomatology, Fujian Medical University

    17 shared publications
  • Zhiyu Cai

    Department of Stomatology, Fujian Medical University Union Hospital, Fuzhou, 350001, China

    16 shared publications
  • Shan Huang

    Clinical Research Center for Oral Tissue Deficiency Diseases of Fujian Province & Fujian Key Laboratory of Oral Diseases & Fujian Provincial Engineering Research Center of Oral Biomaterial, School and Hospital of Stomatology, Fujian Medical University

    14 shared publications
  • Shan Jiang

    Fujian Key Laboratory of Oral Diseases & Fujian Provincial Engineering Research Center of Oral Biomaterial & Stomatological Key Lab of Fujian College and University, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China

    13 shared publications
  • Yijun Li

    Clinical Research Center for Oral Tissue Deficiency Diseases of Fujian Province & Fujian Key Laboratory of Oral Diseases & Fujian Provincial Engineering Research Center of Oral Biomaterial, School and Hospital of Stomatology, Fujian Medical University

    12 shared publications
  • Jingyun Du

    Clinical Research Center for Oral Tissue Deficiency Diseases of Fujian Province & Fujian Key Laboratory of Oral Diseases & Fujian Provincial Engineering Research Center of Oral Biomaterial, School and Hospital of Stomatology, Fujian Medical University

    11 shared publications

Latest Publications

  • Open Access

    Membrane vesicle heterogeneity of Streptococcus mutans is associated with strain-specific cariogenicity

    by Han Wang, Wen Zhou, Yousheng Zeng, Yazhuo Li, Yuze Yang, Yu Zeng, Guowu Gan, Shuai Chen, Xiaojing Huang

    Streptococcus mutans (S. mutans) is a major etiological agent of dental caries, and pronounced heterogeneity in cariogenic phenotypes exists among different strains. The membrane vesicles (MVs) of S. mutans participate in biofilm formation, and their yield and cargo composition vary with environmental conditions. The relationship between MVs and strain-specific differences in cariogenicity remains unclear. The cariogenic potential of the strains was validated using a rat caries model, and strain-specific cariogenic phenotypes were correlated with MV abundance, physicochemical properties, biological functions, and proteomic composition. Compared with MVs from weakly cariogenic strains, those derived from highly cariogenic strains were larger in size and greater in quantity. These MVs reversed defects in biofilm formation, extracellular matrix synthesis, and acid production in UA159 ΔgtfBC. Increased exopolysaccharide synthesis and eDNA accumulation strengthened the biofilm matrix architecture and upregulated the transcription of the acidogenesis-related gene ldh in recipient bacteria. Proteomic analyses revealed that MVs from highly cariogenic strains exhibited distinct protein cargo profiles enriched in multiple virulence-associated proteins, including Gtfs. MVs derived from S. mutans strains display clear strain‑dependent heterogeneity. The differences in physicochemical properties, secretion abundance, biological functions, and protein cargo are associated with cariogenic potential.

  • Open Access

    Integrative transcriptomic and single-cell analyses identify Candida-responsive MMP10, CA9, and STC2 candidates in oral squamous cell carcinoma

    by Jian Xie, Dehua Zeng, Peining Zheng, Kenneth K. Y. Cheng, Jordy Evan Sulaiman, Xiaojing Huang, Guowu Gan

    Background: Oral squamous cell carcinoma (OSCC) arises at a microbially exposed mucosa, but the relationship between tumor transcriptional programs and host responses to Candida albicans is uncertain. We sought direction-consistent genes shared with short-term C. albicans stimulation and assessed their diagnostic, cellular, pathway, and tissue contexts. Methods: We directionally integrated four paired C. albicans -stimulated/control oral-epithelial experiments (GSE56091) with 40 paired OSCC/adjacent tissues (GSE37991). Four machine-learning methods prioritized candidates, and independent bulk validation used 167 OSCCs and 45 controls (GSE30784). An exploratory ridge score was fixed in the discovery cohort and applied to the external cohort. Cellular localization and state were examined in paired single-cell profiles from seven patients (GSE198315) and an external oral-cavity subset of 10 carcinomas and three normal-mucosa samples (GSE181919). Qualitative PAS and IHC assessment used archival oral tissues from three groups, with four cases per group. Results: Candida stimulation yielded 508 exploratory differentially expressed genes, and OSCC yielded 1,850; 26 of 35 overlapping genes changed concordantly. The four-method intersection comprised MMP10 , CA9 , and STC2 ; external single-gene AUCs were 0.968, 0.714, and 0.907, respectively. The three-gene score achieved an external AUC of 0.959 (95% CI 0.935-0.983), but at the discovery-derived cutoff sensitivity was 0.605 and specificity was 1.000; calibration was poor, and discrimination did not exceed MMP10 alone (DeLong P = 0.365). In GSE198315, paired epithelial pseudobulk supported MMP10 and CA9 under prespecified targeted three-gene correction (FDR = 0.0455 for both), whereas STC2 was directional but nonsignificant (FDR = 0.0665). Genome-wide FDR was approximately 0.892 for each gene, so the single-cell findings support localization and directional consistency rather than definitive genome-wide differential expression. The q95 calls showed modest overlap with CopyKAT and inferCNV (Jaccard=0.141 and 0.254, respectively). MMP10 and CA9 showed stronger pooled descriptive localization than STC2 ; CA9 remained hypoxia-associated. Fungal-element-compatible PAS staining provided morphological context but could neither identify species nor quantify burden. Conclusions: MMP10 and CA9 had the strongest multi-level support as direction-consistent Candida -responsive OSCC candidates, while STC2 remains exploratory. The three-gene combination is not yet a calibrated clinical model, and the 26-gene overlap defines a shared host-response pattern rather than evidence that C. albicans causes the OSCC transcriptional state.

  • Open Access

    Candida albicans in oral squamous cell carcinoma: a review of mechanistic pathways and clinical translational strategies

    by Peining Zheng, Qin Xie, Kenneth K. Y. Cheng, Jordy Evan Sulaiman, Xiaojing Huang, Guowu Gan

    Oral squamous cell carcinoma (OSCC) develops within a complex mucosal ecosystem in which microbial dysbiosis, epithelial injury, inflammation, and immune remodeling interact with established carcinogenic exposures. Although Candida albicans has repeatedly been associated with OSCC and oral potentially malignant disorders (OPMDs), its causal and translational significance remains uncertain. This review critically evaluates clinical, microbiological, mechanistic, and translational evidence, with particular attention to the distinction between association, biological plausibility, and causal inference. Current evidence is more consistent with context-dependent tumor-promoting activity than with independent carcinogenicity. Proposed mechanisms include acetaldehyde- and nitrosamine-related genotoxicity, inflammatory and immune-microenvironment remodeling, virulence factor-mediated epithelial injury, and biofilm-associated persistence; however, no single mechanism has been established as necessary or sufficient for Candida -associated tumor promotion. Longitudinal human evidence supports an association between increased fungal burden and malignant transformation in OPMDs, but no validated fungal-burden, virulence, or immune-cell threshold currently distinguishes colonization from pathological amplification. Candidate biomarkers, risk-stratification approaches, and fungal-directed interventions therefore remain investigational. Future studies should integrate standardized longitudinal sampling, spatially resolved fungal–bacterial–host analysis, and functional perturbation to determine whether C. albicans provides reproducible incremental value for clinical risk assessment or therapeutic targeting.

  • Open Access

    Recent advances in membrane vesicles of Streptococcus mutans : biogenesis, regulations, and functions

    by Han Wang, Yuqing Chen, Huilin Huang, Ruonan Chen, Shuai Chen, Xiaojing Huang

    S treptococcus mutans (S. mutans) is one of the predominant pathogens responsible for human dental caries. As ubiquitous constituents of the oral microbiome, S. mutans serves a primary function in ...


  • Open Access

    Development of a novel pH-responsive anti-caries nanocomposite hydrogel

    by Yuqing Zhang, Iris Xiaoxue Yin, Veena Wenqing Xu, Jiang Chen, Xiaojing Huang, Chun Hung Chu

  • Open Access

    Evolutionary applications of electrical stimulation in bone repair: bibliometric trends and temporal dynamics

    by Xiuqing Wang, Jiachen Liu, Yuping Huang, Xiaojing Huang

    Bone defects cause life-threatening risks and reduced quality of life. Researchers are advancing electrical stimulation technologies through sustained innovation to address these challenges. This review used a dual analytical approach integrating bibliometric analysis and expert modeling to systematically evaluate the evolution and trends of electrical stimulation in bone regeneration. A total of 2,069 publications from the Web of Science Core Collection met the inclusion criteria. Early-stage research focused on electrical properties of bone and electrical stimulation stimulator design. Recent trends show growing emphasis on novel material discovery and optimization for electrical stimulation applications. The field was undergoing rapid expansion, engaging growing numbers of countries, institutions, and researchers worldwide.

  • Open Access

    Design and Development of Teixobactin Analog-Loaded Magnetic Nanocomposites for Biofilm Destruction and Pathogen Elimination

    by Huaxiang Lei, Ye Liang, Xuechen Li, Xiaojing Huang, Chengfei Zhang, Ting Zou

    Although teixobactin, a promising cyclic undecadepsipeptide, exhibits efficacy against Gram-positive bacteria due to its novel mode of action and low potential for resistance, its clinical application is limited by two key shortcomings: ineffectiveness against Gram-negative bacteria and poor penetration of the protective extracellular polymeric substance (EPS) in biofilms. This renders it unsuitable for targeting the polymicrobial biofilms, which are the cause of periodontitis and peri-implantitis. We designed a modified teixobactin analog by integrating rhamnolipid, Ag@Fe3O4 nanoparticles, and L-Chg10-teixobactin to obtain a novel magnetic nanoparticle (MNP). The MNP demonstrates the ability to simultaneously degrade EPS, penetrate biofilm structures, and eliminate both G+ and G− pathogens under a rotating magnetic field (RMF). Rhamnolipid grafting degraded 52.5% of biofilm EPS. MNPs showed broad-spectrum antimicrobial activity, with minimal inhibitory concentrations from 100 to 200 µg/mL. Combined with RMF, biofilm eradication rates reached 97.0% (E. faecalis), 97.7% (S. gordonii), 88.4% (P. gingivalis), and 74.2% (F. nucleatum). The biofilm thickness was reduced from 19.4 ± 2.9 µm to 7.4 ± 1.0 µm, and the biofilm biomass was reduced by 68.5%. This combined strategy integrates enzymatic EPS degradation, magneto-mechanical disruption, and dual antimicrobial action, offering a promising topical therapy for periodontitis and peri-implantitis.